Data: 08/08/2026
Total encontrado: 150
1/150Câncer
Fonseca MEF, Waterson AP. Absence of BKV T-antigen antibodies, in patients with leukemia and aplatic anemia. Acta Oncológica Brasileira, São Paulo: Fundação Antônio Prudente (menção de responsabilidade), v.4, n.1-2-3, p. 18-20, 1984. ISSN 0100-3127.

Disponível em: http://accamargo.phlnet.com.br/Acta/AOB19844(1-3)p.18-20.pdf

BKV T-ANTIGEN; LEUKEMIA; APLASTIC ANEMIA


2/150Câncer
Watanabe S, Tahara E, Oguro Y, Bevilacqua RG, Chammas R, Medeiros AC, Nagai MA, Mourão Neto M, Brentani RR, Koike MAA, Roela RA, Barbosa EM, Federico MHH, Brentani MM, Ibrahin R, Parise Junior O, Villa LL, Linne S, Kowalski LP, Snitcovsky I, Curado MP. Fisrt Brazil-Japan cencer meeting - São Paulo, Brazil - December, 1994 abstracts. Acta Oncológica Brasileira, São Paulo: Fundação Antônio Prudente (menção de responsabilidade), v.16, n.3, p. 104-112, 1996. ISSN 0100-3127.

Disponível em: http://accamargo.phlnet.com.br/Acta/AOB199616(3)p.104-12.pdf

GASTRIC CANCER; BREAST CANCER; HEAD AND NECK CANCER; SKIN CANCER; LEUKEMIA


3/150Câncer
Bognone RAV, França BAL, Vassallo J, Lorand-Metze I, Lima CSP. Del(11)(q23) in acute leukemia secondary to treatment of solidtumor. Applied Cancer Research, São Paulo: Tecmedd, v.26, n.2, p. 73-75, 2006. ISSN 1808-5512.

Disponível em: http://accamargo.phlnet.com.br/applied/ACR200626p.73-5.pdf

CANCER; TUMORES SOLIDOS; LEUCEMIA


4/150US=9 / Transplante
Machado LN. Papel do enfermeiro nas diferentes fases do TMO. In: Machado LN, Camandoni VO, Leal KPH, Moscatello ELM. Transplante de medula óssea: abordagem multidisciplinar. São Paulo: Lemar, 2009. p. 59-67.

FASE PRE-TMO; DOADOR; AVALIACAO DO DOADOR; AVALIACAO DO RECEPTOR; MOBILIZACAO; COLETA; PREOCESSAMENTO DAS CELULAS-TRONCO; CATETER VENOSO CENTRAL; UNIDADE DE INTERNACAO; REGIME DE CONDICIONAMENTO; INFUSAO DE CELULAS-TRONCO HEMATOPOIETICAS; DIA "ZERO"; FASE DE APLASIA MEDULAR; CATETER CENTRAL; ENXERTO; FALENCIA; REJEICAO DO ENXERTO; DECH (DOENCA DO ENXERTO CONTRA HOSPEDEIRO); GVL (GRAFT VERSUS LEUKEMIA); ALTA HOSPITALAR; CONSIDERACOES TARDIAS


5/150US=9 / Câncer
Jabbour E, Borthakur G, Bueso-Ramos C, Kantarjan HN, Faderl S. Acute lymphoblastic leukemia. In: Kantarjian HM. The MD Anderson manual of medical oncology. New York: McGraw-Hill, 2006. p. 3-17.

EPIDEMIOLOGIA; ETIOLOGIA; LKEUCEMIA LINFOBLASTICA AGUDA; CITOGENETICA E ANORMALIDADES MOLECULARES; ANORMALIDADES LABORATORIAIS; MORFOLOGIA; HISTOCITOQUIMICA; QUIMIOTERAPIA; TRANSPLANTE DE CELULAS TRONCO; TERAPIA DE RECUPERACAO


6/150US=9 / Câncer
Casas C, Bueso-Ramos C, Estey E. Acute myeologenous leukemia. In: Kantarjian HM. The MD Anderson manual of medical oncology. New York: McGraw-Hill, 2006. p. 19-38.

EPIDEMIOLOGIA; ETIOLOGIA; FATORES DE RISCO; DIAGNOSTICO INICIAL; LEUCEMIA AGUDA; DIAGNOSTICO; CLASSIFICACAO; TRATAMENTO ESPECIFICO; AML EM IDOSO; TRANSPLANTE DE CELULAS TRONCO; CITOGENETICA; IMUNOFENOTIPAGEM; MOLECULAR


7/150US=9 / Câncer
Borthakur G, Bueso-Ramos CE, O'Brien S. Chronic lymphocytic leukemia and associated disorders. In: Kantarjian HM. The MD Anderson manual of medical oncology. New York: McGraw-Hill, 2006. p. 39-55.

EPIDEMIOLOGIA; BIOLOGIA; ORIGEM CELULAR; CITOGENETICA; RESISTENCIA A APOPTOSIS; DIAGNOSTICO; DIAGNOSTICO DIFERENCIAL; ESTAGIO; PROGNOSTICO; AGENTES ALQUILANTES; ANTICORPOS MONOCLONAIS; TRANSPLANTE DE CELULAS TRONCO; SINDROME RICHTER'S; TRANSFORMACAO PROLINFOCITICA; LEUCEMIA DE CELULAS PILOSAS; LEUCEMIA PROLINFOCITICA


8/150US=9 / Câncer
Ghelani D, Sneed TB, Bueso-Ramos CE, Cortes J. Chronic myeloid leukemia. In: Kantarjian HM. The MD Anderson manual of medical oncology. New York: McGraw-Hill, 2006. p. 57-74.

EPIDEMIOLOGIA; ETIOLOGIA; BIOLOGIA DE CML; HISTORIA NATURAL; DIAGNOSTICO INICIAL; PROGNOSTICO; TRANSPLANTE DE CELULAS TRONCO; TRATAMENTO DIRECIONADO


9/150US=90 / Câncer
Uckun FM, Sensel MG. SCID mouse models of human leukemia and lymphoma as tools for new agent development. In: Teicher BA. Tumor models in cancer research. New Jersey: Humana press, 2002. p. 521-40.

LEUCEMIA MIELOIDE HUMANO; LINFOMA HUMANO; DOENCA MIELOIDE; LINFOMA


10/150US=23-E / Câncer
Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. v.6. 480 p. ISBN 978-90-481-2917-1.

11/150US=32 / Câncer
Gribber JB, Harris NL, Dalla-Favera R. Small B-cell lymphocytic lymphoma/chronic lymphocytic leukemia. In: Armitage JO, Mauch PM, Harris NL, Coiffer B, Dalla-Favera R. Non-Hodkin lymphomas. 2ªed. Philadelphia: J.B. Lippincott Company, 2010. p. 196-216. ISBN 978-0-7817-9116-8.

LINFOMA DE CELULAS B PEQUENAS LINFOCITICA; LEUCEMIA LINFOCITICA CRONICA; LEUCEMIA PRO-LINFOCITICA B; LEUCEMIA PRO-LINFOCITICA T


12/150US=32 / Câncer
Foucar K, Osuji N, Matutes E, Dearden C, Catovsky D. T-cell chronic lymphocytic leukemia. In: Armitage JO, Mauch PM, Harris NL, Coiffer B, Dalla-Favera R. Non-Hodkin lymphomas. 2ªed. Philadelphia: J.B. Lippincott Company, 2010. p. 393-403. ISBN 978-0-7817-9116-8.

CELULAS T; LEUCEMIA LINFOCITICA CRONICA; LEUCEMIA DE CELULAS T; LEUCEMIA PROLINFOCITICA TIPO CELULAS T


13/150US=32 / Câncer
Tobinai K, Watanabe T, Jaffe ES. Human T-cell leukemia virus type I-associated adult T-cell leukemia lymphoma. In: Armitage JO, Mauch PM, Harris NL, Coiffer B, Dalla-Favera R. Non-Hodkin lymphomas. 2ªed. Philadelphia: J.B. Lippincott Company, 2010. p. 404-14. ISBN 978-0-7817-9116-8.

CELULAS T; LINFOMA LEUCEMIA DE CELULAS T


14/150US=11 / Laboratório
Herbes A, Pauw BE. Acute myelogenous leukemia and febrile neutropenia. In: Kleinberg M. Managing infections in patients with hematological malignancies. New Jersey: Humana Press, 2010. p. 137-71. (Contemporary Hematology) ISBN 978-1-58829-986-4.

NEUTROPENIA FEBRIL; TERAPEUTICA ANTIBACTERIANA EMPIRICA; FEBRE INEXPLICAVEL; IMUNODEFICIENCIA; FUNGO INVASIVO


15/150US=11 / Laboratório
Rolston KVI. Lymphomas and chronic lymphocytic leukemia. In: Kleinberg M. Managing infections in patients with hematological malignancies. New Jersey: Humana Press, 2010. p. 173-87. (Contemporary Hematology) ISBN 978-1-58829-986-4.

DOENTES COM NEOPLASIAS HEMATOLOGICAS; NEOPLASIAS HEMATOLOGICAS; PACIENTES DE BAIXO RISCO; INFECCOES FUNGICAS; INFECCOES VIRAIS; TERAPIA AMBULATORIAL


16/150US=23-E / Câncer
Alcázar JL. Distinguishing benign from malignant complex adnexal masses in ovarian cancer: two-dimensional power-doppler imaging. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 23-33. ISBN 978-90-481-2917-1.

DISTINGUIR BENIGNAS DAS MALIGNAS; MASSAS ANEXIAIS EM CANCER DE OVARIO


17/150US=23-E / Câncer
Boylan KLM, Skubitz KM, Skubitz APN. Subgroups of ovarian carcinoma: identification using differential gene expression. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 35-58. ISBN 978-90-481-2917-1.

CANCER DO OVARIO; CARCINOMA DE OVARIO


18/150US=23-E / Câncer
Sur M, Daya D. Sertolifrom: endometrioid carcinoma of the ovary: diagnosis and prognosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 59-68. ISBN 978-90-481-2917-1.

SERTOLIFROM; CARCINOMA DO OVARIO; ENDOMETRIOID; CARCINOMA DO OVARIO. DIAGNOSTICO; CARCINOMA DO OVARIO. TRATAMENTO


19/150US=23-E / Câncer
Gubbels JAA, Connor JP, Patankar MS. Role of MUC16 (CA125) in the pathogenesis of epithelial ovarian cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 71-84. ISBN 978-90-481-2917-1.

MUC16; CA125 NA PATOGENESE DO CANCER EPITELIAL DE OVARIO; CANCER EPITELIAL DE OVARIO; CAMADAS DE DEFESA DO TUMOR DAS CELULAS


20/150US=23-E / Câncer
Takano M, Sasaki N, Sugiyama T. Clear cell carcinoma of the ovary: prognosis using cytoreductive surgery. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 85-91. ISBN 978-90-481-2917-1.

CARCINOMA DE CELULAS CLARAS DO OVARIO; CIRURGIA CITOSTATICA


Primeira | Anterior | Próxima | Última